# A Multicentre European Study to Evaluate Granulox® Used in the Treatment Pathway of Predominantly Chronic Venous Leg Ulcers (VLUs).

> **NCT04181320** · NA · TERMINATED · sponsor: **Molnlycke Health Care AB** · enrollment: 128 (actual)

## Conditions studied

- Venous Leg Ulcer

## Interventions

- **DEVICE:** Venous Leg Ulcer Standard of Care with Granulox

## Key facts

- **NCT ID:** NCT04181320
- **Lead sponsor:** Molnlycke Health Care AB
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-06-08
- **Primary completion:** 2023-01-17
- **Final completion:** 2023-01-17
- **Target enrollment:** 128 (ACTUAL)
- **Why stopped:** Results of interim analysis
- **Last updated:** 2024-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04181320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04181320, "A Multicentre European Study to Evaluate Granulox® Used in the Treatment Pathway of Predominantly Chronic Venous Leg Ulcers (VLUs).". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04181320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*